Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jae Eun Choi

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Neoplasia (New York, N.Y.)|February 24, 2019
Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell CarcinomaJae Eun Choi, Monique E Verhaegen, Sahr Yazdani, et al.
Cancer Discovery|September 27, 2019
Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11Xueting Lang, Michael D Green, Weimin Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive BiomarkersKelly L Harms, Lili Zhao, Bryan Johnson, et al.
Cancer Cell|January 29, 2021
Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistanceHeng Lin, Ilona Kryczek, Shasha Li, et al.
Nature|May 14, 2025
STAT5 and STAT3 balance shapes dendritic cell function and tumour immunityJiajia Zhou, Kole Tison, Haibin Zhou, et al.
Cancer Discovery|November 14, 2024
The UBA1-STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint BlockadeYi Bao, Gabriel Cruz, Yuping Zhang, et al.
Nature Communications|June 28, 2024
PIKfyve, expressed by CD11c-positive cells, controls tumor immunityJae Eun Choi, Yuanyuan Qiao, Ilona Kryczek, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
PIKfyve controls dendritic cell function and tumor immunityJae Eun Choi, Yuanyuan Qiao, Ilona Kryczek, et al.
Nature|May 3, 2019
CD8<sup>+</sup> T cells regulate tumour ferroptosis during cancer immunotherapyWeimin Wang, Michael Green, Jae Eun Choi, et al.
Cancer Cell|January 13, 2023
Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapyGaopeng Li, Jae Eun Choi, Ilona Kryczek, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Neoplasia (New York, N.Y.)|February 24, 2019
Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell CarcinomaJae Eun Choi, Monique E Verhaegen, Sahr Yazdani, et al.
Cancer Discovery|September 27, 2019
Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11Xueting Lang, Michael D Green, Weimin Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive BiomarkersKelly L Harms, Lili Zhao, Bryan Johnson, et al.
Cancer Cell|January 29, 2021
Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistanceHeng Lin, Ilona Kryczek, Shasha Li, et al.
Nature|May 14, 2025
STAT5 and STAT3 balance shapes dendritic cell function and tumour immunityJiajia Zhou, Kole Tison, Haibin Zhou, et al.
Cancer Discovery|November 14, 2024
The UBA1-STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint BlockadeYi Bao, Gabriel Cruz, Yuping Zhang, et al.
Nature Communications|June 28, 2024
PIKfyve, expressed by CD11c-positive cells, controls tumor immunityJae Eun Choi, Yuanyuan Qiao, Ilona Kryczek, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
PIKfyve controls dendritic cell function and tumor immunityJae Eun Choi, Yuanyuan Qiao, Ilona Kryczek, et al.
Nature|May 3, 2019
CD8<sup>+</sup> T cells regulate tumour ferroptosis during cancer immunotherapyWeimin Wang, Michael Green, Jae Eun Choi, et al.
Cancer Cell|January 13, 2023
Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapyGaopeng Li, Jae Eun Choi, Ilona Kryczek, et al.
Pageof 7